These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8077767)

  • 21. Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
    Buchwalder PA; Buclin T; Trinchard I; Munafo A; Biollaz J
    J Interferon Cytokine Res; 2000 Oct; 20(10):857-66. PubMed ID: 11054273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
    Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
    J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta.
    Witt PL; Storer BE; Bryan GT; Brown RR; Flashner M; Larocca AT; Colby CB; Borden EC
    J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):191-200. PubMed ID: 8471593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C].
    Daito K; Suou T; Kawasaki H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914
    [No Abstract]   [Full Text] [Related]  

  • 25. Recombinant human interferon-beta (rHuIFN-beta) and radiation therapy for inoperable non-small cell lung cancer.
    Byhardt RW; Vaickus L; Witt PL; Chang AY; McAuliffe T; Wilson JF; Lawton CA; Breitmeyer J; Alger ME; Borden EC
    J Interferon Cytokine Res; 1996 Nov; 16(11):891-902. PubMed ID: 8938564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological effects of recombinant interferon-beta administered intravenously daily in phase I trial.
    Borden EC; Hawkins MJ; Sielaff KM; Storer BM; Schiesel JD; Smalley RV
    J Interferon Res; 1988 Jun; 8(3):357-66. PubMed ID: 3045221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of 2'-5'-oligoadenylate synthetase in serum and peripheral blood mononuclear cells before and after subcutaneous application of recombinant interferon beta and gamma.
    Bruchelt G; Fierlbeck G; Schiebel U; Bogenschütz O; Rassner G; Niethammer D
    Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):521-8. PubMed ID: 1457613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha.
    Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J
    J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical and immunological responses of hairy cell leukemia patients to interferon beta.
    Liberati AM; Horisberger M; Schippa M; Di Clemente F; Fizzotti M; Filippo S; Proietti MG; Arzano S; Berruto P; Palmisano L
    Cancer Immunol Immunother; 1991; 34(2):115-22. PubMed ID: 1760815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I/IB study of polyadenylic-polyuridylic acid in patients with advanced malignancies: clinical and biologic effects.
    Witt PL; Zahir S; Ritch PS; McAuliffe TM; Ewel CH; Borden EC
    J Interferon Cytokine Res; 1996 Aug; 16(8):631-5. PubMed ID: 8877734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2',5'-oligoadenylate synthetase activity in murine liver.
    Yamagata Y; Yuasa Y; Yamamoto K; Okamoto K; Igari Y; Iga K; Ogawa Y
    J Interferon Cytokine Res; 2000 Feb; 20(2):153-60. PubMed ID: 10714550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
    Daito K; Suou T; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men.
    Barouki FM; Witter FR; Griffin DE; Nadler PI; Woods A; Wood DL; Lietman PS
    J Interferon Res; 1987 Feb; 7(1):29-39. PubMed ID: 3035034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical host response to interferon-beta.
    Liberati AM; Fizzotti M; Proietti MG; Di Marzio R; Schippa M; Biscottini B; Senatore M; Berruto P; Canali S; Peretti G
    J Interferon Res; 1988 Dec; 8(6):765-77. PubMed ID: 3068316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 2',5'-oligoadenylate synthetase and B-2 microglobulin in cancer patients treated with partially pure gamma interferon: dependence of biological effect on administration route.
    Rosenblum MG; Riso A; Gutterman JU
    Cancer Chemother Pharmacol; 1986; 16(3):273-6. PubMed ID: 3084109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-beta induced biochemical and immunological modifications in hairy cell leukemia patients.
    Liberati AM; Schippa M; Portuesi MG; Grazia Proietti M; De Angelis V; Ferrajoli A; Cinieri S; Di Clemente F; Palmisano L; Berruto P
    Haematologica; 1991; 76(5):375-82. PubMed ID: 1806440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia.
    Aulitzky WE; Peschel C; Desprès D; Aman J; Trautman P; Tilg H; Rudolf G; Hüttmann H; Obermeier J; Herold M
    Ann Hematol; 1993 Nov; 67(5):205-11. PubMed ID: 7694661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers.
    García-García I; Hernández-González I; Díaz-Machado A; González-Delgado CA; Pérez-Rodríguez S; García-Vega Y; Campos-Mojena R; Tuero-Iglesias ÁD; Valenzuela-Silva CM; Cruz-Ramírez A; Martín-Trujillo A; Santana-Milián H; López-Saura PA; Bello-Rivero I;
    BMC Pharmacol Toxicol; 2016 Dec; 17(1):58. PubMed ID: 27923408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum concentrations of 2',5'-oligoadenylate synthetase, neopterin, and beta-glucan in patients with chronic fatigue syndrome and in patients with major depression.
    Matsuda J; Gohchi K; Gotoh N
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):1015-6. PubMed ID: 8057103
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.